Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer

Clinical trial NCT00032188 · COMPLETED

Trial details

NCT number: NCT00032188
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2002-01-01
Primary completion: 2006-06-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.